| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 11 |
| 1 | RISANKIZUMAB-RZAA | 5 |
| 2 | COPPER | 4 |
| 3 | ELAGOLIX AND ESTRADIOL AND NORETHISTERONE | 4 |
| 4 | UPADACITINIB | 4 |
| 5 | DUPILUMAB | 3 |
| 6 | ESTRADIOL | 3 |
| 7 | ESTRADIOL GEL 0.1% | 3 |
| 8 | ESTRADIOL TRANSDERMAL | 3 |
| 9 | ESTRADIOL, | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELAGOLIX AND ESTRADIOL AND NORETHISTERONE | 4 | 0.0067 |
| 1 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| 2 | NICARDIPINE HYDROCHLORIDE | 1 | 0.0004 |
| 3 | SUGAMMADEX | 1 | 0.0004 |
| 4 | OXYTOCIN | 1 | 0.0003 |
| 5 | FLUOROMETHOLONE | 1 | 0.0003 |
| 6 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 7 | NICARDIPINE | 1 | 0.0002 |
| 8 | METHYLDOPA | 1 | 0.0002 |
| 9 | ATOGEPANT | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Oxytocic [EPC] | 1 | 0.0003 |
| 2 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 5 | Copper-containing Intrauterine Device [EPC] | 4 | 0.0001 |
| 6 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 8 | Interleukin-23 Antagonist [EPC] | 5 | 0.0000 |
| 9 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |